- Report
- January 2022
- 200 Pages
Global
From €5216EUR$5,250USD£4,337GBP
€7451EUR$7,500USD£6,195GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 200 Pages
Global
From €5216EUR$5,250USD£4,337GBP
€7451EUR$7,500USD£6,195GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Drug Pipelines
- October 2021
- 50 Pages
United States
From €1565EUR$1,575USD£1,301GBP
€2235EUR$2,250USD£1,859GBP
- Report
- August 2020
- 80 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- August 2020
- 80 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- July 2019
Global
From €695EUR$700USD£578GBP
€993EUR$1,000USD£826GBP
- Report
- November 2023
- 174 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 178 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 71 Pages
India
From €3477EUR$3,500USD£2,891GBP
- Report
- October 2023
- 182 Pages
Global
From €4471EUR$4,500USD£3,717GBP
The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more